Aehr Test Systems specializes in test and burn-in solutions for semiconductors, with particular exposure to silicon carbide and advanced packaging for AI processors. The fiscal 2026 fourth quarter marked the end of the company’s fiscal year on May 29, 2026. Investors closely monitor these results because Aehr’s revenue can fluctuate with large system orders from hyperscale customers. Recent quarters showed volatility tied to customer order timing, making the latest report a key indicator of demand trends in the AI infrastructure supply chain and the company’s path toward sustained profitability. To get a quick sense of how AEHR compares within the broader semiconductor equipment group, I ran a scan using Tickeron’s AI Screener.
Aehr Test Systems delivered fiscal 2026 fourth-quarter revenue of $18.8 million, an increase from $14.1 million in the same quarter of fiscal 2025. GAAP net income totaled $1.4 million, or $0.04 per diluted share, reversing a prior-year GAAP net loss of $2.9 million, or $0.10 per diluted share. Non-GAAP net income, which excludes stock-based compensation and other items, reached $3.6 million, or $0.11 per diluted share. Quarterly bookings set a new record at $60.7 million. The company also provided updates on its full-year performance and noted that fiscal 2026 revenue is expected to land on the high side of the previously guided $45 million to $50 million range.
Shares of AEHR moved higher following the July 14, 2026, earnings release, driven by the record bookings figure and the return to GAAP profitability. Investors focused on the strong book-to-bill ratio and visibility into future revenue from AI-related demand. Sentiment heading into the report had been cautious amid prior-quarter variability, but the positive surprise on bookings helped shift focus toward growth prospects in the semiconductor test equipment sector.
Investors will watch how Aehr converts its elevated backlog into recognized revenue over the coming quarters. The company expects fiscal 2026 second-half revenue between $25 million and $30 million, with non-GAAP net loss per diluted share between $(0.09) and $(0.05). Continued strength in orders for package-level burn-in systems serving custom AI processors remains a central theme.
Management reiterated expectations for full-year fiscal 2026 revenue to finish on the high end of the $45 million to $50 million range. Key areas to monitor include follow-on production orders from the lead hyperscale customer, progress on silicon carbide customer expansions, and any updates to fiscal 2027 guidance during future earnings calls.
Broader industry dynamics, such as capital spending trends among semiconductor manufacturers and hyperscale data center operators, will also influence Aehr’s trajectory. Margin performance and the timing of large system deliveries are additional factors that could affect quarterly results.
One thing that stands out when reviewing results like these is how much faster pattern and signal analysis becomes with the right tools. I often turn to Tickeron’s AI Screener to filter stocks by industry, technical indicators, and performance metrics. It helps surface comparable names or spot broader trends without manually combing through dozens of charts. In my view, incorporating an AI-driven screener into the workflow adds efficiency when evaluating companies exposed to AI infrastructure spending, though it remains just one part of a broader review process.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
AEHR moved below its 50-day moving average on June 26, 2026 date and that indicates a change from an upward trend to a downward trend. In of 35 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on June 26, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In of 83 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on June 23, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .
The 10-day moving average for AEHR crossed bearishly below the 50-day moving average on July 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 251 cases where AEHR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 55, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (16.313) is normal, around the industry mean (10.222). P/E Ratio (19.449) is within average values for comparable stocks, (95.645). AEHR's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.845). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (48.077) is also within normal values, averaging (96.471).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment